Brad dahms theseus

Author: hfey

August undefined, 2024

WebJun 2, 2024 · (2024-06-02 NYSE:BIO) Theseus Pharmaceuticals Appoints Brad Dahms as Chief Financial Officer. Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with … WebBrad Dahms is Chief Financial Officer of Theseus Pharmaceuticals. Brad most recently served as Chief Financial Officer of Selecta Biosciences, Inc. (NASDAQ: SELB), where he oversaw financial operations, investor relations, and business development activities. He led Selecta through several significant financing and strategic transactions ...

Bradford Dahms - Chief Financial Officer - Theseus

WebJun 2, 2024 · Theseus Pharmaceuticals, a biotechnology company shaping the future of targeted oncology by developing best-in-class, pan-variant kinase inhibitors, today announced the appointment of Brad Dahms as Chief Financial Officer, a biotechnology company shaping the future of targeted oncology by developing best-in-class, pan … WebTheseus is headquartered in Cambridge, Massachusetts, United States and was established in 2024. Read More. Contact. Who is Theseus. Headquarters. 245 Main St, Cambridge, Massachusetts, 02142, United States. Phone Number (857) 400-9491. ... Theseus's CFO is Bradford Dahms How do I contact Theseus? Theseus contact info: … screw thread cleaner

EX-10.12 - SEC

WebJun 2, 2024 · CAMBRIDGE, Mass., June 2, 2024 /PRNewswire/ -- Theseus Pharmaceuticals, a biotechnology company shaping the future of targeted oncology by … WebTheseus Pharmaceuticals, Inc. THRX i Nasdaq 8,333,500 shares (100% primary) $14.00 to $16.00 per share $125 million (assuming midpoint of IPO pricing range and excluding Overallotment Option) 1,250,025 shares (15% of the base offering shares) The Company intends to use the net proceeds from this offering. WebSep 10, 2024 · Theseus Pharmaceuticals, Inc. September 10, 2024 . Brad Dahms [***] Dear Brad: Theseus Pharmaceuticals, Inc. (the “Company”), is pleased to offer you … paynes forest creek

Brad Dahms on LinkedIn: Theseus Pharmaceuticals …

WebGet Brad Dahms's email address (b*****@theseusrx.com) and phone number (302540....) at RocketReach. Get 5 free searches. ... Chief Financial Officer @ Theseus Pharmaceuticals. Preparing Brad profile… View Brad's Email & Phone (It's Free) 5 free lookups per month. No credit card required. Location. Boston, MA, US. Work. Chief … WebTHESEUS PHARMACEUTICALS, INC. is a Connecticut Foreign Stock filed on July 5, 2024. The company's filing status is listed as Active and its File Number is 2587462. The … paynes fordWebFounder of Theseus Pharmaceuticals, Inc., Victor M. Rivera currently is Chief Scientific Officer at this company. In his past career Dr. Rivera held the position of VP-Preclinical & Translational Research at ARIAD Pharmaceuticals, Inc. He received a doctorate from Harvard Medical School and an undergraduate degree from Princeton University. paynes florist benbrook texas

"WebGet Brad Dahms's email address (b*****@theseusrx.com) and phone number (302540....) at RocketReach. Get 5 free searches. Rocketreach finds email, phone & social media for … " - Brad dahms theseus

Brad dahms theseus

Theseus Pan-Variant Tyrosine Kinase Inhibitors

WebMarch 10, 2024 and Theseus' Form 10-Q for the quarter ended March 31, 2024 expected to be filed with the SEC in the second quarter of 2024. However, new risk factors ... Brad Dahms. CFO. Former CFO, Selecta Biosciences ©2024 Theseus Pharmaceuticals. WebTHESEUS PHARMACEUTICALS, INC. was registered on Jul 05, 2024 as a stock type company located at 314 Main Street, 04-200, Cambridge, MA, 02142, United States . ... Brad Dahms / CFO . 314 Main Street, 04-200, Cambridge, MA, 02142, United States . Filings Details . Filing Type ...

Did you know?

WebNov 1, 2024 · Theseus Pharmaceuticals Presents Preclinical Data Characterizing THE-349, its Fourth-Generation EGFR Inhibitor in Development for NSCLC, at the 34th EORTC-NCI-AACR Symposium. Oct 19, 2024. ... Theseus Pharmaceuticals Appoints Brad Dahms as Chief Financial Officer. May 4, 2024. WebCongratulations to Stern IR client, Disc Medicine, who announced this morning a $62.5M registered direct offering led by Bain Capital! #biotech…. Liked by Brad Dahms. …

Web©2024 Theseus Pharmaceuticals. Certain statements included in this presentation are not historical facts but are forward- looking statements for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward- looking statements generally are accompanied by words such as "believe," … WebJun 2, 2024 · Jun. 2, 2024, 07:00 AM. CAMBRIDGE, Mass., June 2, 2024 /PRNewswire/ -- Theseus Pharmaceuticals, a biotechnology company shaping the future of targeted …

WebTheseus Pharmaceuticals, a biotechnology company shaping the future of targeted oncology by developing best-in-class, pan-variant kinase inhibitors, today announced the … WebBrad Dahms. CFO. Former CFO, Selecta Biosciences ©2024 Theseus Pharmaceuticals. Extensive experience and track record in TKI discovery, development, and commercialization. Many members of leadership team worked together for …

WebGet William Shakespeare's email address (w*****@theseusrx.com) and phone number (708-261-....) at RocketReach. Get 5 free searches.

WebThe organizational chart of Theseus Pharmaceuticals displays its 21 main executives including Tim Clackson, Brad Dahms and David Kerstein × We use cookies to provide a better service. By continuing your navigation, you consent to their use. screw thread crosswordWebBrad Dahms is Chief Financial Officer of Theseus Pharmaceuticals. Brad most recently served as Chief Financial Officer of Selecta Biosciences, Inc. (NASDAQ: SELB), where … paynes ford rd martinsburg wvWebJan 18, 2024 · Klein Hersh supports Theseus Pharmaceuticals on the appointment of Brad Dahms as Chief Financial Officer June 2, 2024. Klein Hersh supports Arbor Biotechnologies Inc on the appointment of John Murphy, Ph.D., as Chief Scientific Officer May 27, 2024. screw thread characteristicsWebAt Theseus Pharmaceuticals, Brad Dahms has 18 colleagues including Tim Clackson (CEO & Director), Kathy Yi (Director)… Industry Colleagues. In the Pharmaceuticals … paynes fruit and vegWebTheseus Pharmaceuticals, a biotechnology company shaping the future of targeted oncology by developing best-in-class, pan-variant kinase inhibitors, today announced the … screw thread connectorsWebTheseus Pharmaceuticals's President & Chief Executive Officer is Timothy P. Clackson. Other executives include Victor Rivera, Co-Founder, Chief Scientific Officer; Brad … paynes forks pfbc2WebMar 19, 2024 · Chief Financial Officer at Theseus . Brad Dahms is Chief Financial Officer of Theseus Pharmaceuticals. Brad most recently served as Chief Financial Officer of … paynes heating